GDF
GILD icon

Graham & Dodd Fund’s Gilead Sciences GILD Stock Holding History

Graham & Dodd Fund’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$690K Sell
9,179
-4,421
-33% -$308K 2.1% 26
2013
Q3 		$855K Buy
+13,600
New +$813K 1.65% 32

Other funds holding GILD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Graham & Dodd Fund's GILD Position: Q4 2013 in Review

Graham & Dodd Fund reduced its Gilead Sciences (GILD) stake by 33% in Q4 2013, selling an estimated $308K and leaving 9,179 shares worth $690K. The position accounts for 2.1% of the portfolio, ranked #26.

Graham & Dodd Fund first reported a position in GILD in Q3 2013 and has held it in 2 quarters since. The position peaked at $855K in Q3 2013. 1,100 funds tracked by Wall St. Rank hold GILD as of Q4 2013.

  • Graham & Dodd Fund held 9,179 shares of Gilead Sciences worth $690K as of Q4 2013.
  • Graham & Dodd Fund sold 4,421 Gilead Sciences shares in Q4 2013, an estimated $308K.
  • Gilead Sciences made up 2.1% of Graham & Dodd Fund's portfolio in Q4 2013, its #26 holding.
  • Graham & Dodd Fund first reported a position in Gilead Sciences in Q3 2013 and has held it in 2 quarters since.
  • Graham & Dodd Fund's Gilead Sciences position peaked at $855K in Q3 2013.
  • 1,100 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2013.

Based on Graham & Dodd Fund's 13F filing for Q4 2013, filed 11 Feb 2014.